Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 156 Neoplasms 115 Colorectal Neoplasms 98 Breast Neoplasms 93 Pancreatic Neoplasms 81 Neoplasm Metastasis 81 Leukemia, Myeloid, Acute 79 Recurrence 76 Prostatic Neoplasms 74 Ovarian Neoplasms 74 Melanoma 74 Multiple Myeloma 66 Stomach Neoplasms 59 Lung Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 55 Triple Negative Breast Neoplasms 50 Glioblastoma 49 Lymphoma 47 Endometrial Neoplasms 43 Carcinoma, Hepatocellular 42 Advanced Solid Tumor 42 Lymphoma, Non-Hodgkin 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Advanced Solid Tumors 37 Small Cell Lung Carcinoma 35 Uterine Cervical Neoplasms 34 Carcinoma, Renal Cell 34 Lymphoma, Large B-Cell, Diffuse 32 Lymphoma, B-Cell 32 Sarcoma 30

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Recruiting × Cancer Related Cognitive Decline × Clear all

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡